ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Versatile DNA-Functionalized Biohybrid Hydrogel Platforms for Electrothermally Activated On-Demand Payload Release.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Current drug delivery systems struggle to achieve precise control, rapid response, and high biocompatibility. Addressing these challenges, we developed an electrothermally responsive biohybrid hydrogel incorporating DNA-functionalized nanostructures for on-demand payload release. Unlike conventional platforms relying on passive diffusion or biochemical triggers, our system utilizes electrical stimulation to produce localized heating that simultaneously alters DNA conformation and hydrogel structure. This dual mechanism enables rapid electrically controlled release within seconds while preserving excellent biocompatibility. The modular DNA design permits easy customization through sequence modifications, enabling flexible adaptation for diverse therapeutic applications, including precision oncology, neural regulation, and chronic wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.